Background: Several Streptococcus pneumoniae proteins play a role in pathogenesis and are being investigated as vaccine targets. It is largely unknown whether naturally acquired antibodies reduce the risk of colonization with strains expressing a particular antigenic variant. Methods: Serum immunoglobulin G (IgG) titers to 28 pneumococcal protein antigens were measured among 242 individuals aged <6 months-78 years in Native American communities between 2007 and 2009. Nasopharyngeal swabs were collected >- 30 days after serum collection, and the antigen variant in each pneumococcal isolate was determined using genomic data. We assessed the association between preexisting variant-specific antibody titers and subsequent carriage of pneumococcus expressing a particular antigen variant. Results: Antibody titers often increased across pediatric groups before decreasing among adults. Individuals with low titers against group 3 pneumococcal surface protein C (PspC) variants were more likely to be colonized with pneumococci expressing those variants. For other antigens, variant-specific IgG titers do not predict colonization. Conclusion: We observed an inverse association between variant-specific antibody concentration and homologous pneumococcal colonization for only 1 protein. Further assessment of antibody repertoires may elucidate the nature of antipneumococcal antibody-mediated mucosal immunity while informing vaccine development.
Background: Several Streptococcus pneumoniae proteins play a role in pathogenesis and are being investigated as vaccine targets. It is largely unknown whether naturally acquired antibodies reduce the risk of colonization with strains expressing a particular antigenic variant. Methods: Serum immunoglobulin G (IgG) titers to 28 pneumococcal protein antigens were measured among 242 individuals aged <6 months-78 years in Native American communities between 2007 and 2009. Nasopharyngeal swabs were collected >- 30 days after serum collection, and the antigen variant in each pneumococcal isolate was determined using genomic data. We assessed the association between preexisting variant-specific antibody titers and subsequent carriage of pneumococcus expressing a particular antigen variant. Results: Antibody titers often increased across pediatric groups before decreasing among adults. Individuals with low titers against group 3 pneumococcal surface protein C (PspC) variants were more likely to be colonized with pneumococci expressing those variants. For other antigens, variant-specific IgG titers do not predict colonization. Conclusion: We observed an inverse association between variant-specific antibody concentration and homologous pneumococcal colonization for only 1 protein. Further assessment of antibody repertoires may elucidate the nature of antipneumococcal antibody-mediated mucosal immunity while informing vaccine development.
Authors: S Rapola; V Jäntti; R Haikala; R Syrjänen; G M Carlone; J S Sampson; D E Briles; J C Paton; A K Takala; T M Kilpi; H Käyhty Journal: J Infect Dis Date: 2000-09-05 Impact factor: 5.226
Authors: Tera L McCool; Thomas R Cate; Elaine I Tuomanen; Peter Adrian; Tim J Mitchell; Jeffrey N Weiser Journal: Infect Immun Date: 2003-10 Impact factor: 3.441
Authors: Merit M Melin; Susan K Hollingshead; David E Briles; Mika I Lahdenkari; Terhi M Kilpi; Helena M Käyhty Journal: Clin Vaccine Immunol Date: 2008-08-27
Authors: Andrew J Page; Carla A Cummins; Martin Hunt; Vanessa K Wong; Sandra Reuter; Matthew T G Holden; Maria Fookes; Daniel Falush; Jacqueline A Keane; Julian Parkhill Journal: Bioinformatics Date: 2015-07-20 Impact factor: 6.937
Authors: Cintia F M Vadesilho; Daniela M Ferreira; Stephen B Gordon; David E Briles; Adriana T Moreno; Maria Leonor S Oliveira; Paulo L Ho; Eliane N Miyaji Journal: Clin Vaccine Immunol Date: 2014-05-07
Authors: Rama Kandasamy; Stephanie Lo; Meeru Gurung; Michael J Carter; Rebecca Gladstone; John Lees; Sonu Shrestha; Stephen Thorson; Sanjeev Bijukchhe; Madhav C Gautam; Reetu Shrestha; Sunaina Gurung; Bibek Khadka; Lesley McGee; Robert F Breiman; David R Murdoch; Dominic F Kelly; Shrijana Shrestha; Stephen D Bentley; Andrew J Pollard Journal: Lancet Microbe Date: 2022-05-09
Authors: Taj Azarian; Lindsay R Grant; Brian J Arnold; Laura L Hammitt; Raymond Reid; Mathuram Santosham; Robert Weatherholtz; Novalene Goklish; Claudette M Thompson; Stephen D Bentley; Katherine L O'Brien; William P Hanage; Marc Lipsitch Journal: PLoS Pathog Date: 2018-04-04 Impact factor: 6.823
Authors: Taj Azarian; Patrick K Mitchell; Maria Georgieva; Claudette M Thompson; Amel Ghouila; Andrew J Pollard; Anne von Gottberg; Mignon du Plessis; Martin Antonio; Brenda A Kwambana-Adams; Stuart C Clarke; Dean Everett; Jennifer Cornick; Ewa Sadowy; Waleria Hryniewicz; Anna Skoczynska; Jennifer C Moïsi; Lesley McGee; Bernard Beall; Benjamin J Metcalf; Robert F Breiman; P L Ho; Raymond Reid; Katherine L O'Brien; Rebecca A Gladstone; Stephen D Bentley; William P Hanage Journal: PLoS Pathog Date: 2018-11-26 Impact factor: 6.823
Authors: Natalie Groves; Carmen L Sheppard; David Litt; Samuel Rose; Ana Silva; Nina Njoku; Sofia Rodrigues; Zahin Amin-Chowdhury; Nicholas Andrews; Shamez Ladhani; Norman K Fry Journal: Genes (Basel) Date: 2019-10-25 Impact factor: 4.096
Authors: Awa L Mendy; Schadrac C Agbla; Aderonke A Odutola; Martin Antonio; Brian M Greenwood; Jayne S Sutherland; Martin O C Ota Journal: PLoS One Date: 2017-10-05 Impact factor: 3.240